- Home
- ALLR vs PSTV Comparison
ALLR vs PSTV Comparison
Compare ALLR & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- PSTV
- Stock Information
- Founded
- ALLR 2004
- PSTV 1996
- Country
- ALLR United States
- PSTV United States
- Employees
- ALLR N/A
- PSTV N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- PSTV Medical/Dental Instruments
- Sector
- ALLR Health Care
- PSTV Health Care
- Exchange
- ALLR Nasdaq
- PSTV Nasdaq
- Market Cap
- ALLR 15.8M
- PSTV 17.0M
- IPO Year
- ALLR N/A
- PSTV N/A
- Fundamental
- Price
- ALLR $0.94
- PSTV $0.49
- Analyst Decision
- ALLR Strong Buy
- PSTV Strong Buy
- Analyst Count
- ALLR 1
- PSTV 4
- Target Price
- ALLR $9.00
- PSTV $8.88
- AVG Volume (30 Days)
- ALLR 367.8K
- PSTV 14.8M
- Earning Date
- ALLR 08-15-2025
- PSTV 08-14-2025
- Dividend Yield
- ALLR N/A
- PSTV N/A
- EPS Growth
- ALLR N/A
- PSTV N/A
- EPS
- ALLR N/A
- PSTV N/A
- Revenue
- ALLR N/A
- PSTV $5,317,000.00
- Revenue This Year
- ALLR N/A
- PSTV $8.26
- Revenue Next Year
- ALLR N/A
- PSTV $8.39
- P/E Ratio
- ALLR N/A
- PSTV N/A
- Revenue Growth
- ALLR N/A
- PSTV N/A
- 52 Week Low
- ALLR $0.61
- PSTV $0.16
- 52 Week High
- ALLR $6.00
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- ALLR 47.03
- PSTV 45.83
- Support Level
- ALLR $0.85
- PSTV $0.45
- Resistance Level
- ALLR $1.01
- PSTV $0.65
- Average True Range (ATR)
- ALLR 0.05
- PSTV 0.11
- MACD
- ALLR -0.01
- PSTV -0.03
- Stochastic Oscillator
- ALLR 47.55
- PSTV 7.93
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).